Methods and compositions related to glucocorticoid receptor antagonists and breast cancer
US12280066B2 · kind B2 · utility
0Cited by
9References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 15, 2023 |
| Grant date | Apr 22, 2025 |
| Priority date | — |
| Expiry date | Dec 15, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Embodiments of the invention are directed to methods of determining the prognosis of a breast cancer patient by evaluating the activity of the glucocorticoid receptor in tumor cells. Other embodiment include methods of treating breast cancer cells, particularly, chemo-resistant cells, with a glucocorticoid receptor antagonist and an anticancer agent or compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.